Small pouches, but high nicotine doses-nicotine delivery and acute effects after use of tobacco-free nicotine pouches.
arterial stiffness
cardiovascular effects
craving reduction
high nicotine doses
nicotine delivery
nicotine pouches
pharmacokinetics
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2024
2024
Historique:
received:
26
02
2024
accepted:
22
04
2024
medline:
6
6
2024
pubmed:
6
6
2024
entrez:
6
6
2024
Statut:
epublish
Résumé
Tobacco-free nicotine pouches are new nicotine products for oral consumption. They can contain very high nicotine amounts that have not been addressed with clinical studies yet. Thus, nicotine delivery, effects on craving, and side effects were assessed using pouches with up to 30 mg nicotine. In this single-center, five-arm, crossover study, 15 regular cigarette smokers consumed tobacco-free nicotine pouches from different brands with 6, 20, and 30 mg for 20 min. Comparators were nicotine-free pouches and tobacco cigarettes. At baseline and predefined time points over a study period of 240 min, plasma nicotine concentrations, effects on cigarette craving, and side effects were assessed. Cardiovascular parameters including arterial stiffness were measured using a MobilOGraph. Consumption of 30 mg nicotine pouches has led to a higher nicotine uptake compared with the cigarette (C
Identifiants
pubmed: 38841367
doi: 10.3389/fphar.2024.1392027
pii: 1392027
pmc: PMC11150668
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1392027Informations de copyright
Copyright © 2024 Mallock-Ohnesorg, Rabenstein, Stoll, Gertzen, Rieder, Malke, Burgmann, Laux, Pieper, Schulz, Franzen, Luch and Rüther.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.